Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Heron Therapeutics Inc (HRTX) vs abrdn Physical Palladium Shares ETF (PALL) Price & Performance

Heron Therapeutics IncTrade
abrdn Physical Palladium Shares ETFTrade

Price performance (Past 24H)

Key statistics

Heron Therapeutics Inc vs abrdn Physical Palladium Shares ETF — how do they compare? Heron Therapeutics Inc trades at $0.32 (market cap $61.47M), while abrdn Physical Palladium Shares ETF trades at $25.46. The key difference: abrdn Physical Palladium Shares ETF is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals.

HRTXPALL
Market Cap
$61.47M
Sector
HealthCommodities - Metals/Agriculture
52-Week High
$1.49$37.18
52-Week Low
$0.32$19.96
Enterprise Value
$168.21M

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Heron Therapeutics Inc

Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.

Read more on HRTX

About abrdn Physical Palladium Shares ETF

PALL is a physically-backed ETF that tracks the spot price of palladium. It holds physical bullion in secure vaults, offering a liquid way to invest in this precious metal primarily used in automotive catalytic converters and electronics.

Read more on PALL